These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19110580)

  • 1. Relationship between oxidized fibrinogen and hemostasis disturbances and endothelial dysfunction in myocardial infarction.
    Ragino YI; Baum VA; Polonskaya YV; Sadovski EV; Baum SR; Nikitin YP
    Bull Exp Biol Med; 2008 Apr; 145(4):412-4. PubMed ID: 19110580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oxidized fibrinogen and its relationship with hemostasis disturbances and endothelial dysfunction during coronary heart disease and myocardial infarction].
    Ragino IuI; Baum VA; Polonskaia IaV; Baum SR; Nikitin IuP
    Kardiologiia; 2009; 49(9):4-8. PubMed ID: 19772496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction.
    Becatti M; Marcucci R; Bruschi G; Taddei N; Bani D; Gori AM; Giusti B; Gensini GF; Abbate R; Fiorillo C
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1355-61. PubMed ID: 24790138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombogenic factors and recurrent coronary events.
    Moss AJ; Goldstein RE; Marder VJ; Sparks CE; Oakes D; Greenberg H; Weiss HJ; Zareba W; Brown MW; Liang CS; Lichstein E; Little WC; Gillespie JA; Van Voorhees L; Krone RJ; Bodenheimer MM; Hochman J; Dwyer EM; Arora R; Marcus FI; Watelet LF; Case RB
    Circulation; 1999 May; 99(19):2517-22. PubMed ID: 10330382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemostasis in patients operated on for abdominal hemorrhage. 4. Conception of hemostasis changes].
    Beliaev AV; Zaremba AM; Platonova TN
    Ukr Biokhim Zh (1978); 1997; 69(5-6):190-5. PubMed ID: 9606844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
    Iba T; Gando S; Murata A; Kushimoto S; Saitoh D; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Ikeda T; Ishhikura H; Ueyama M; Ogura Y; Endo S; Shimazaki S;
    J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostatic abnormalities in patients with severe preeclampsia.
    Heilmann L; Rath W; Pollow K
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):285-91. PubMed ID: 17636190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Laboratory signs of activation of the hemostasis system in patients with coronary heart disease, who had coronary artery bypass surgery.].
    Lisyutenko NS; Morova NA; Tsekhanovich VN
    Klin Lab Diagn; 2018; 63(8):500-505. PubMed ID: 30726655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor--results from patients with acute myocardial infarction and healthy controls.
    Reininger AJ; Agneskirchner J; Bode PA; Spannagl M; Wurzinger LJ
    Thromb Haemost; 2000 Feb; 83(2):217-23. PubMed ID: 10739376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease.
    Smith FB; Lowe GD; Fowkes FG; Rumley A; Rumley AG; Donnan PT; Housley E
    Atherosclerosis; 1993 Sep; 102(2):155-62. PubMed ID: 8251001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic abnormalities in acute myocardial infarction as detected by specific blood markers.
    Tanaka M; Suzuki A
    Thromb Res; 1994 Nov; 76(3):289-98. PubMed ID: 7863479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myocardial necrosis in coronary disease].
    Baroldi G
    G Ital Cardiol; 1974; 4(5):521-6. PubMed ID: 4435321
    [No Abstract]   [Full Text] [Related]  

  • 13. [Procedure for determination of oxidative modification of plasma fibrinogen].
    Ragino IuI; Baum VA; Polonskaia IaV; Gromov AA
    Klin Lab Diagn; 2007 Jan; (1):13-6. PubMed ID: 17385436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemostatical and rheological aspects of dysfibrinogenemia.
    Mörsdorf S; Jung F; Seyfert UT; Mrowietz C; Pindur G; Wenzel E
    Clin Hemorheol Microcirc; 1997; 17(1):13-9. PubMed ID: 9181754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of hemostasis in patients with myocardial infarction complicated by deep venous thrombosis].
    Lewandowski K; Psuja P; Zozulińska M; Turowiecka Z; Zawilska K
    Pol Arch Med Wewn; 1990 Aug; 84(2):79-85. PubMed ID: 2277786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
    ; Danesh J; Lewington S; Thompson SG; Lowe GD; Collins R; Kostis JB; Wilson AC; Folsom AR; Wu K; Benderly M; Goldbourt U; Willeit J; Kiechl S; Yarnell JW; Sweetnam PM; Elwood PC; Cushman M; Psaty BM; Tracy RP; Tybjaerg-Hansen A; Haverkate F; de Maat MP; Fowkes FG; Lee AJ; Smith FB; Salomaa V; Harald K; Rasi R; Vahtera E; Jousilahti P; Pekkanen J; D'Agostino R; Kannel WB; Wilson PW; Tofler G; Arocha-Piñango CL; Rodriguez-Larralde A; Nagy E; Mijares M; Espinosa R; Rodriquez-Roa E; Ryder E; Diez-Ewald MP; Campos G; Fernandez V; Torres E; Marchioli R; Valagussa F; Rosengren A; Wilhelmsen L; Lappas G; Eriksson H; Cremer P; Nagel D; Curb JD; Rodriguez B; Yano K; Salonen JT; Nyyssönen K; Tuomainen TP; Hedblad B; Lind P; Loewel H; Koenig W; Meade TW; Cooper JA; De Stavola B; Knottenbelt C; Miller GJ; Cooper JA; Bauer KA; Rosenberg RD; Sato S; Kitamura A; Naito Y; Palosuo T; Ducimetiere P; Amouyel P; Arveiler D; Evans AE; Ferrieres J; Juhan-Vague I; Bingham A; Schulte H; Assmann G; Cantin B; Lamarche B; Després JP; Dagenais GR; Tunstall-Pedoe H; Woodward M; Ben-Shlomo Y; Davey Smith G; Palmieri V; Yeh JL; Rudnicka A; Ridker P; Rodeghiero F; Tosetto A; Shepherd J; Ford I; Robertson M; Brunner E; Shipley M; Feskens EJ; Kromhout D; Dickinson A; Ireland B; Juzwishin K; Kaptoge S; Lewington S; Memon A; Sarwar N; Walker M; Wheeler J; White I; Wood A
    JAMA; 2005 Oct; 294(14):1799-809. PubMed ID: 16219884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of fibrinogen and fibrin degradation products (DFP) in the acute stage of myocardial infarction].
    Baele G; Mussche M; Vermeire P; Pannier R
    Arch Mal Coeur Vaiss; 1973 Apr; 66(4):427-9. PubMed ID: 4198846
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of soluble fibrin monomer complexes (SFMC) and plasma fibrinogen in acute myocardial infarction.
    Jain SM; Trivedi S
    Indian J Chest Dis Allied Sci; 1984; 26(2):98-103. PubMed ID: 6530267
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrinogen degradation products.
    Sack ES; Buraschi J
    N Engl J Med; 1971 Jun; 284(25):1441. PubMed ID: 5578330
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemostatic changes in patients with peripheral artery disease before and after bypass surgery].
    Kalinin RE; Suchkov IA; Mzhavanadze ND; Demikhov VG; Zhurina ON; Klimentova EA
    Khirurgiia (Mosk); 2018; (8):46-49. PubMed ID: 30113592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.